{"id":"W4385667085","doi":"10.1097/01.hs9.0000971256.60488.02","title":"P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Venetoclax; Ibrutinib; Medicine; Mantle cell lymphoma; Obinutuzumab; Internal medicine; Bendamustine; Regimen; Oncology; Adverse effect; Gastroenterology; Lymphoma; Rituximab; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001964828,0.0001715181,0.0002950602,0.00006380622,0.0001434592,0.0000289563,0.0001315965,0.0001011662,0.0002339383],"category_scores_gemma":[0.0001077697,0.0001080421,0.00005791779,0.0005865683,0.0002480159,0.00008151122,0.0001297992,0.0001882076,0.00006942342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003443077,"about_ca_system_score_gemma":0.002342613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000290342,"about_ca_topic_score_gemma":0.0001002635,"domain_scores_codex":[0.998443,0.00005263,0.0002339723,0.0002877407,0.0006052473,0.0003773796],"domain_scores_gemma":[0.9988769,0.0002434439,0.0000995091,0.0004464505,0.0002079521,0.000125695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004750903,0.0005136262,0.8490034,0.004031408,0.001558572,0.0007910357,0.008988517,0.0003982199,0.001975132,0.002542911,0.04599991,0.07944635],"study_design_scores_gemma":[0.1487146,0.00262448,0.8127386,0.003151012,0.000633331,0.000228533,0.002063068,0.01576784,0.009248661,0.0003078373,0.003766247,0.0007558515],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955654,0.0004136512,0.0000187284,0.0002204018,0.00009933045,0.0006985689,0.00001003919,0.00008695244,0.002886969],"genre_scores_gemma":[0.9937017,0.00005759052,0.00005389745,0.00006590662,0.00004104504,0.00003004117,0.00009072074,0.00004472094,0.005914356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1439636,"threshold_uncertainty_score":0.9003527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01498899969128477,"score_gpt":0.2636121938561011,"score_spread":0.2486231941648164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}